[1] |
Kuypers DR. Management of polyomavirus-associated nephropathy in renal transplant recipients[J]. Nat Rev Nephrol, 2012, 8(7): 390-402.
|
[2] |
AST Infectious Diseases Community of Practice; Hirsch HH, Randhawa P. BK polyomavirus in solid organ transplantation[J]. Am J Transplant, 2013,13(Suppl 4): S179-S188.
|
[3] |
Huang G, Zhang L, Liang X, et al. Risk factors for BK virus infection and BK virus-associated nephropathy under the impact of intensive monitoring and pre-emptive immunosuppression reduction[J]. Transplant Proc, 2014, 46(10): 3448-3454.
|
[4] |
孙忠蔚,范宇,柏宏伟,等. 他克莫司代谢率与肾移植术后早期BK病毒感染的关系[J]. 器官移植,2018, 4(9): 278-282.
|
[5] |
Drachenberg CB, Hirsch HH, Papadimitriou JC, et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: Aprospective evaluation[J]. Transplantation, 2007, 84(3): 323-330.
|
[6] |
范宇,石炳毅,钱叶勇,等. 肾移植术后BK病毒感染对移植肾功能影响的临床研究[J]. 器官移植,2018, 9(1): 51-57.
|
[7] |
Bohl DL, Brennan DC. BK virus nephropathy and kidney transplantation[J]. Clin J Am Soc Nephrol, 2007, 2(Suppl 1):S36-S46.
|
[8] |
Kasiske BL, Zeier MG, Chapman JR, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary[J]. Kidney Int, 2010, 77(4): 299-311.
|
[9] |
Randhawa P, Ho A, Shapiro R, et al. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients[J]. J Clin Microbiol, 2004, 42(3): 1176-1180.
|
[10] |
Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients[J]. Am J Transplant, 2009, 9(Suppl 3):S1-S155.
|
[11] |
Drachenberg CB, Papadimitriou JC, Hirsch HH, et al. Histological patterns of polyomavirus nephropathy: Correlation with graft outcome and viral load[J]. Am J Transplant, 2004, 4(12): 2082-2092.
|
[12] |
Czyżewski Ł, Wyzgał J, Czyżewska E, et al. Performance of the MDRD, CKD-EPI, and Cockcroft-Gault formulas in relation to nutritional status in stable renal transplant recipients[J]. Transplant Proc, 2016, 48(5): 1494-1497.
|
[13] |
Sawinski D, Goral S. BK virus infection: an update on diagnosis and treatment[J]. Nephrol Dial Transplant, 2015, 30(2): 209-217.
|
[14] |
Sood P, Senanayake S, Sujeet K, et al. Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study[J]. Transplantation, 2012, 94(8): 814-821.
|
[15] |
Elfadawy N, Flechner SM, Schold JD, et al. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation[J]. Clin J Am Soc Nephrol, 2014, 9(3): 553-561.
|
[16] |
Jacobi J, Prignitz A, Büttner M, et al. BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition[J]. BMC Nephrol, 2013, 14: 207
|